HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Hagiwara Selected Research

A Hagiwara Research Topics

Disease

20Neoplasms (Cancer)
01/2020 - 03/2000
12Stomach Neoplasms (Stomach Cancer)
03/2008 - 03/2000
6Neoplasm Metastasis (Metastasis)
01/2019 - 03/2000
5Carcinoma (Carcinomatosis)
07/2005 - 08/2000
4Carcinogenesis
02/2005 - 01/2001
4Lymphatic Metastasis
11/2001 - 03/2000
2Brain Neoplasms (Brain Tumor)
11/2021 - 01/2019
2Wounds and Injuries (Trauma)
05/2017 - 09/2001
2Neoplasm Micrometastasis
03/2008 - 02/2004
2Body Weight (Weight, Body)
07/2005 - 08/2003
2Adenoma (Adenomas)
09/2001 - 03/2001
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Ischemic Stroke
11/2021
1Epilepsy (Aura)
11/2021
1Melanoma (Melanoma, Malignant)
01/2020
1Fibrosis (Cirrhosis)
01/2020
1Hypopituitarism (Sheehan's Syndrome)
01/2020
1Hypophysitis
01/2020
1Brain Injuries (Brain Injury)
05/2017
1Hemorrhage
05/2017
1Vertigo (Positional Vertigo)
02/2015
1Meniere Disease (Menieres Disease)
02/2015
1Intestinal Diseases (Diseases, Intestinal)
09/2010
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2009
1Esophageal Neoplasms (Esophageal Cancer)
08/2007
1Hemiplegia (Spastic Hemiplegia)
12/2005
1Colorectal Neoplasms (Colorectal Cancer)
07/2005
1Peptic Ulcer (Peptic Ulcers)
02/2005
1Hepatocellular Carcinoma (Hepatoma)
03/2004
1Hypertrophy
08/2003
1Ascites
11/2002
1Peritonitis
10/2001
1Aberrant Crypt Foci
09/2001
1Pyloric Stenosis
04/2001
1Pathologic Constriction (Stenosis)
04/2001
1Aneuploidy (Aneuploid)
03/2001
1Hyperplasia
03/2001
1Adenocarcinoma
03/2001

Drug/Important Bio-Agent (IBA)

3Messenger RNA (mRNA)IBA
03/2008 - 09/2001
3Carcinoembryonic AntigenIBA
03/2008 - 09/2001
3Dextran SulfateIBA
10/2001 - 06/2000
3CarbonIBA
10/2001 - 03/2000
2Contrast MediaIBA
01/2019 - 07/2005
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
02/2004 - 11/2002
2DNA (Deoxyribonucleic Acid)IBA
11/2002 - 03/2001
2Methotrexate (Mexate)FDA LinkGeneric
10/2001 - 03/2000
1Biomarkers (Surrogate Marker)IBA
01/2022
1Bevacizumab (Avastin)FDA Link
01/2022
1SodiumIBA
11/2021
1Immune Checkpoint InhibitorsIBA
01/2020
1Hormones (Hormone)IBA
01/2020
1GadoliniumIBA
01/2019
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2019
1Tranexamic Acid (AMCA)FDA Link
05/2017
1Volatile Fatty AcidsIBA
09/2010
1Lactic Acid (Lactate)FDA LinkGeneric
09/2010
1Retinaldehyde (Retinal)IBA
01/2009
1Transforming Growth Factors (Transforming Growth Factor)IBA
08/2007
1Transforming Growth Factor beta (TGF-beta)IBA
08/2007
1Monoclonal AntibodiesIBA
07/2005
1ferumoxides (Feridex)FDA Link
07/2005
1ferric oxide (iron oxide)IBA
07/2005
1beta Carotene (Betacarotene)FDA Link
07/2005
1TE 5IBA
10/2004
1Cadherins (E-Cadherin)IBA
03/2004
1Matrix Metalloproteinases (MMPs)IBA
03/2004
1Dopa DecarboxylaseIBA
02/2004
1Complementary DNA (cDNA)IBA
02/2004
1norbixinIBA
08/2003
1annattoIBA
08/2003
1Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA
11/2002
1Integrin beta4IBA
11/2002
1Interleukin-2 Receptors (IL 2 Receptor)IBA
11/2002
1Aldehyde DehydrogenaseIBA
11/2002
1Keratins (Keratin)IBA
11/2002
1Saline SolutionIBA
10/2001
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
10/2001
1SolutionsIBA
10/2001
1PicibanilIBA
10/2001
1Tissue Adhesives (Tissue Adhesive)IBA
10/2001
1Anthocyanins (Anthocyanin)IBA
09/2001
11,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
09/2001
1benzocycloheptapyridineIBA
09/2001
12- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
09/2001
1Dimenhydrinate (DMH)FDA LinkGeneric
09/2001
1Phosphotransferases (Kinase)IBA
03/2001
1catechol (pyrocatechol)IBA
03/2001
1Anti-Bacterial Agents (Antibiotics)IBA
03/2001

Therapy/Procedure

6Gastrectomy
02/2005 - 03/2000
3Drug Therapy (Chemotherapy)
02/2004 - 04/2000
3Lymph Node Excision (Lymph Node Dissection)
10/2000 - 06/2000
2Radiotherapy
08/2007 - 10/2004
2Therapeutics
04/2001 - 06/2000
1Middle Ear Ventilation (Tympanostomy)
02/2015
1Aftercare (After-Treatment)
02/2015
1Foot Orthoses
12/2005
1Operative Surgical Procedures
10/2001
1Laparotomy
09/2001
1Truncal Vagotomy
04/2001
1Activities of Daily Living (ADL)
03/2001